These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 22992666)

  • 21. Getting personal: the promises and potential pitfalls of personalized medicine.
    Ozer BH
    Virtual Mentor; 2012 Aug; 14(8):601-3. PubMed ID: 23351312
    [No Abstract]   [Full Text] [Related]  

  • 22. Personalized medicine: will dentistry ride the wave or watch from the beach?
    Kornman KS; Duff GW
    J Dent Res; 2012 Jul; 91(7 Suppl):8S-11S. PubMed ID: 22699674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Actors and tools of predictive genetics: ethics at the heart of governance].
    Cambon-Thomsen A
    J Int Bioethique; 2014 Jun; 25(2):159-68, 176. PubMed ID: 25272800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Company profile: Sequenom, Inc.
    Cantor CR
    Pharmacogenomics; 2012 Apr; 13(5):529-31. PubMed ID: 22462745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Personalized medicine gets practical.
    Sanders D; Kmiecik T
    Healthc Inform; 2009 May; 26(5):50-1. PubMed ID: 19514241
    [No Abstract]   [Full Text] [Related]  

  • 26. On rat poison and human medicines: personalizing warfarin therapy.
    Frueh FW
    Trends Mol Med; 2012 Apr; 18(4):201-5. PubMed ID: 22382089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [PERSONALIZED MEDICINE AND EBM: ETHICAL ASPECTS].
    Radermecker RP
    Rev Med Liege; 2015; 70(5-6):343-6. PubMed ID: 26285464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Just caring: assessing the ethical and economic costs of personalized medicine.
    Fleck LM
    Urol Oncol; 2014 Feb; 32(2):202-6. PubMed ID: 24445288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Group-based and personalized care in an age of genomic and evidence-based medicine: a reappraisal.
    Maglo KN
    Perspect Biol Med; 2012; 55(1):137-54. PubMed ID: 22643722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining 'medical necessity' in an age of personalised medicine: A view from Canada.
    Caulfield T; Zarzeczny A
    Bioessays; 2014 Sep; 36(9):813-7. PubMed ID: 25059840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Personalized medicine - the promised land: are we there yet?
    Li C
    Clin Genet; 2011 May; 79(5):403-12. PubMed ID: 21204795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Personalized medicine: marking a new epoch in cancer patient management.
    Diamandis M; White NM; Yousef GM
    Mol Cancer Res; 2010 Sep; 8(9):1175-87. PubMed ID: 20693306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Personalized medicine: ethics for clinical trials.
    Sharrer GT
    Methods Mol Biol; 2012; 823():35-48. PubMed ID: 22081337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging landscape of genomics in the Electronic Health Record for personalized medicine.
    Ullman-Cullere MH; Mathew JP
    Hum Mutat; 2011 May; 32(5):512-6. PubMed ID: 21309042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomics and personalized medicine.
    Sadee W
    Int J Pharm; 2011 Aug; 415(1-2):2-4. PubMed ID: 21539903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How novel molecular diagnostic technologies and biomarkers are revolutionizing genetic testing and patient care.
    Baudhuin LM; Donato LJ; Uphoff TS
    Expert Rev Mol Diagn; 2012 Jan; 12(1):25-37. PubMed ID: 22133117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Personalized or person-centered medicine? Their synthesis in an integrative and personalized healthcare supply].
    Neugebauer E; Heusser P
    Gesundheitswesen; 2014 Nov; 76(11):694-5. PubMed ID: 25462618
    [No Abstract]   [Full Text] [Related]  

  • 38. Is there an imperative for generic profiling to hasten the age of personalized medicine.
    Somberg J
    Am J Ther; 2012 May; 19(3):163. PubMed ID: 22565850
    [No Abstract]   [Full Text] [Related]  

  • 39. Current challenges in personalizing warfarin therapy.
    McMillin GA; Vazquez SR; Pendleton RC
    Expert Rev Clin Pharmacol; 2011 May; 4(3):349-62. PubMed ID: 22114781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The rhetorical construction of ethical positions: policy recommendations for nontherapeutic genetic testing in childhood.
    Hogben S; Boddington P
    Commun Med; 2006; 3(2):135-46. PubMed ID: 17129202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.